Translational Development AcTDACU
13F holders, Q2 2025 (June 30)9holders −12
1new positions
2sold out
1famous investor
$10.34avg. 13F price*
At the end of Q2 2025, 9 institutions reported holding Translational Development Ac (TDACU) in their 13F filings, down 12 from Q1 2025. 1 opened new positions and 2 sold out. The largest holders were Alberta Investment Management Corp ($6.2M), Rivernorth Capital Management, LLC ($5.1M) and Calamos Advisors LLC ($3.9M). One famous investor held it David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio).
- Company
- Translational Development Ac
- CUSIP
- G9008W121
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $6.2M |
| Exits | 2 | $765K |
All 13F filers, Q1 2025 → Q2 2025: 603,854 shares bought and 75,400 shares sold, net +528,454 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Alberta Investment Management Corp | 0.05% | New | 600,000 | $6.2M |
| Rivernorth Capital Management, LLC | 0.29% | No change | 500,000 | $5.1M |
| Calamos Advisors LLC | 0.02% | No change | 375,000 | $3.9M |
| MMCAP International Inc. SPC | 0.44% | No change | 350,000 | $3.6M |
| D. E. Shaw & Co. | 0.00% | No change | 350,000 | $3.6M |
| Two Sigma Investments, LP | 0.00% | No change | 133,325 | $1.4M |
| Yakira Capital Management, Inc. | 0.23% | No change | 60,000 | $621K |
| Flow Traders U.S. LLC | 0.01% | Add +37.1% | 14,228 | $146K |
| UBS Group AG | 0.00% | No change | 8,330 | $86K |
"% of holder's portfolio" is TDACU's weight in each manager's 13F, not the share of Translational Development Ac the manager owns.